dapsone has been researched along with hydrazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Hein, DW; Weber, WW | 1 |
| Drayer, DE; Freundlich, B; Lorenzo, B; Reidenberg, MM; Snyder, ES; Stolley, PD; Strom, BL; West, SL | 1 |
| Diez-Ewald, M; Vizcaíno, G; Vizcaíno-Carruyo, J | 1 |
| Audia, S; Bonnotte, B; Godeau, B | 1 |
| Aboud, N; Depré, F; Mayer, B; Salama, A | 1 |
2 review(s) available for dapsone and hydrazine
| Article | Year |
|---|---|
N-acetylation pharmacogenetics.
Topics: Acebutolol; Acetyl Coenzyme A; Acetylation; Acetyltransferases; Aminoglutethimide; Animals; Anti-Anxiety Agents; Benzodiazepines; Caffeine; Carcinogens; Cricetinae; Dapsone; Disease; Drug-Related Side Effects and Adverse Reactions; Ethnicity; Genotype; Humans; Hydrazines; Kinetics; Liver; Mice; Models, Biological; Mutagens; Pharmaceutical Preparations; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Procainamide; Rabbits; Species Specificity; Substrate Specificity; Sulfasalazine | 1985 |
[Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review].
Topics: Adrenal Cortex Hormones; Antigens, Human Platelet; Autoantibodies; Benzoates; Blood Platelets; Clinical Trials as Topic; Combined Modality Therapy; Cost-Benefit Analysis; Dapsone; Helicobacter Infections; Helicobacter pylori; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Models, Immunological; Molecular Mimicry; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Splenectomy; Thrombopoiesis | 2009 |
5 other study(ies) available for dapsone and hydrazine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.
Topics: Acetylation; Adult; Amines; Dapsone; Environmental Exposure; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Male; Middle Aged; Phenotype; Smoking | 1993 |
Is there still a place for "old therapies" in the management of immune thrombocytopenia?
Topics: Benzoates; Danazol; Dapsone; Humans; Hydrazines; Hydroxychloroquine; Immunoglobulins, Intravenous; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thrombopoietin; Vinca Alkaloids | 2016 |
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Benzoates; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Dapsone; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Retrospective Studies; Rho(D) Immune Globulin; Rituximab; Splenectomy; Thrombopoietin; Treatment Outcome; Young Adult | 2018 |